In summary, the SPOP-SRC-3 axis serves as a crucial regulatory mechanism in breast cancer, with therapeutic interventions aimed at restoring this pathway potentially improving outcomes and overcoming resistance in patients. Here, NCOA3 is linked to breast cancer.